Macrophage and dendritic cell subsets in IBD: ALDH+ cells are reduced in colon tissue of patients with ulcerative colitis regardless of inflammation

Mucosal Immunology

Volumn 9, Issue 1, 2016, Pages 171-182

  Magnusson, M K ^a   Brynjolfsson S F ^a   Dige, A ^b   Uronen Hansson, H ^c   Borjesson L G ^d   Bengtsson, J L ^d   Gudjonsson, S ^e   Ohman L ^a   Agnholt, J ^b   Sjovall H ^a   Agace, W W ^c,f   Wick, M J ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c LUND UNIVERSITY   (Sweden)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

^f TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE; RETINOIC ACID; ALPHA E INTEGRINS; ALPHA INTEGRIN; BLOOD DENDRITIC CELL ANTIGEN 3, HUMAN; CD1 ANTIGEN; CD14 ANTIGEN; CD1C PROTEIN, HUMAN; GLYCOPROTEIN; GLYCOPROTEIN P 15095; HLA DR ANTIGEN; LEUKOCYTE ANTIGEN; MEMBRANE ANTIGEN;

ADULT; AGED; ARTICLE; CD14- DENDRITIC CELL; CD14- MACROPHAGE; CD141+ CD103+ DENDRITIC CELL; CD1C+ CD103+ DENDRITIC CELL; CELL COMPOSITION; CELL FRACTIONATION; CELL POPULATION; COLON; CONTROLLED STUDY; CROHN COLITIS; CROHN ILEITIS; DENDRITIC CELL; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; ILEUM; INFLAMMATORY BOWEL DISEASE; LAMINA PROPRIA; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MESENTERY LYMPH NODE; PRIORITY JOURNAL; ULCERATIVE COLITIS; VITAMIN METABOLISM; ADOLESCENT; CASE CONTROL STUDY; CROHN DISEASE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INTESTINE MUCOSA; LYMPH NODE; MIDDLE AGED; PATHOLOGY; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALDEHYDE DEHYDROGENASE; ANTIGENS, CD; ANTIGENS, CD1; ANTIGENS, CD11C; ANTIGENS, CD14; ANTIGENS, SURFACE; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; COLON; CROHN DISEASE; DENDRITIC CELLS; FEMALE; GENE EXPRESSION REGULATION; GLYCOPROTEINS; HLA-DR ANTIGENS; HUMANS; INTEGRIN ALPHA CHAINS; INTESTINAL MUCOSA; LYMPH NODES; MACROPHAGES; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION;

EID: 84953227102     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2015.48     Document Type: Article

References (52)

1. Scott, C.L., Aumeunier, A.M., & Mowat, A.M. Intestinal CD103+ dendritic cells: master regulators of tolerance? Trends Immunol 32, 412-419 (2011
2. Bain, C.C., & Mowat, A.M. Intestinal macrophages-specialised adaptation to a unique environment. Eur J Immunol 41, 2494-2498 (2011
3. Bain C.C., et al. Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6Chi monocyte precursors. Mucosal Immunol 6, 498-510 (2013
4. Rivollier, A., He, J., Kole, A., Valatas, V., & Kelsall, B.L. Inflammation switches the differentiation program of Ly6Chi monocytes from antiinflammatory macrophages to inflammatory dendritic cells in the colon. J Exp Med 209, 139-155 (2012
5. Maloy, K.J., & Powrie, F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 474, 298-306 (2011
6. Tamoutounour S., et al. CD64 distinguishes macrophages from dendritic cells in the gut and reveals the Th1-inducing role of mesenteric lymph node macrophages during colitis. Eur J Immunol 42, 3150-3166 (2012
7. Smith P.D., et al. Intestinal macrophages lack CD14 and CD89 and consequently are down-regulated for LPS-And IgA-mediated activities. J Immunol 167, 2651-2656 (2001
8. Smythies L.E., et al. Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J Clin Invest 115, 66-75 (2005
9. Kamada N., et al. Human CD14+ macrophages in intestinal lamina propria exhibit potent antigen-presenting ability. J Immunol 183, 1724-1731 (2009
10. Kamada N., et al. Unique CD14 intestinal macrophages contribute to the pathogenesis of Crohn disease via IL-23/IFN-g axis. J Clin Invest 118, 2269-2280 (2008
11. Thiesen, S., et al. CD14hiHLA-DRdim macrophages, with a resemblance to classical blood monocytes, dominate inflamed mucosa inCrohn's disease. J Leukoc Biol 95, 531-541 (2014
12. Ogino T., et al. Increased Th17-inducing activity of CD14+ CD163low myeloid cells in intestinal lamina propria of patients with Crohn's disease. Gastroenterology 145, 1380-1391 e1381 (2013
13. Baba N., et al. CD47 fusion protein targets CD172a+ cells in Crohn's disease and dampens the production of IL-1b and TNF. J Exp Med 210, 1251-1263 (2013
14. Dillon S.M., et al. Human intestinal lamina propria CD1c+ dendritic cells display an activated phenotype at steady state and produce IL-23 in response to TLR7/8 stimulation. J Immunol 184, 6612-6621 (2010
15. Hart A.L., et al. Characteristics of intestinal dendritic cells in inflammatory bowel diseases. Gastroenterology 129, 50-65 (2005
16. Baumgart D.C., et al. Exaggerated inflammatory response of primary human myeloid dendritic cells to lipopolysaccharide in patients with inflammatory bowel disease. Clin Exp Immunol 157, 423-436 (2009
17. Iliev I.D., et al. Human intestinal epithelial cells promote the differentiation of tolerogenic dendritic cells. Gut 58, 1481-1489 (2009
18. Sakuraba A., et al. Th1/Th17 immune response is induced by mesenteric lymph node dendritic cells in Crohn's disease. Gastroenterology 137, 1736-1745 (2009
19. Rimoldi M., et al. Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells. Nat Immunol 6, 507-514 (2005
20. Cerovic V., et al. Intestinal CD103- dendritic cells migrate in lymph and prime effector T cells. Mucosal Immunol 6, 104-113 (2013
21. Persson E.K., et al. IRF4 transcription-factor-dependent CD103+ CD11b+ dendritic cells drive mucosal T helper 17 cell differentiation. Immunity 38, 958-969 (2013
22. Bogunovic M., et al. Origin of the lamina propria dendritic cell network. Immunity 31, 513-525 (2009
23. Bekiaris, V., Persson, E.K., & Agace, W.W. Intestinal dendritic cells in the regulation of mucosal immunity. Immunol Rev 260, 86-101 (2014
24. Watchmaker, P.B et al. Comparative transcriptional and functional profiling defines conserved programs of intestinal DC differentiation in humans and mice. Nat Immunol 15, 98-108 (2014
25. Schlitzer A., et al. IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses. Immunity 38, 970-983 (2013
26. Welty N.E., et al. Intestinal lamina propria dendritic cells maintain T cell homeostasis but do not affect commensalism. J Exp Med 210, 2011-2024 (2013
27. Agace, W.W., & Persson, E.K. How vitamin A metabolizing dendritic cells are generated in the gut mucosa. Trends Immunol 33, 42-48 (2012
28. Hall, J.A., Grainger, J.R., Spencer, S.P., & Belkaid, Y. The role of retinoic acid in tolerance and immunity. Immunity 35, 13-22 (2011
29. Jaensson E., et al. Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans. J Exp Med 205, 2139-2149 (2008
30. Langlet C., et al. CD64 expression distinguishes monocyte-derived and conventional dendritic cells and reveals their distinct role during intramuscular immunization. J Immunol 188, 1751-1760 (2012
31. Haniffa M., et al. Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells. Immunity 37, 60-73 (2012
32. Villadangos, J.A., & Shortman, K. Found in translation: the human equivalent of mouse CD8+ dendritic cells. J Exp Med 207, 1131-1134 (2010
33. Johansson-Lindbom B., et al. Functional specialization of gut CD103+ dendritic cells in the regulation of tissue-selective Tcell homing. J Exp Med 202, 1063-1073 (2005
34. Schulz, O., et al. Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions. J Exp Med 206, 3101-3114 (2009
35. Yu C.I., et al. Human CD1c+ dendritic cells drive the differentiation of CD103+ CD8+ mucosal effector Tcells via the cytokine TGF-b. Immunity 38, 818-830 (2013
36. Bai A., et al. All-Trans retinoic acid down-regulates inflammatory responses by shifting the Treg/Th17 profile in human ulcerative and murine colitis. J Leukoc Biol 86, 959-969 (2009
37. Sanders T.J., et al. Increased production of retinoic acid by intestinal macrophages contributes to their inflammatory phenotype in patients with Crohn's disease. Gastroenterology 146, 1278-1288 (2014
38. Moreb, J.S., et al. The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistance. Chem Biol Interact 195, 52-60 (2012
39. Khor, B., Gardet, A., & Xavier, R.J. Genetics and pathogenesis of inflammatory bowel disease. Nature 474, 307-317 (2011
40. Huttenhower, C., Kostic, A.D., & Xavier, R.J. Inflammatory bowel disease as a model for translating the microbiome. Immunity 40, 843-854 (2014
41. Tremaroli, V., & Backhed, F. Functional interactions between the gut microbiota and host metabolism. Nature 489, 242-249 (2012
42. Moco S., et al. Systems biology approaches for inflammatory bowel disease: emphasis on gut microbial metabolism. Inflamm Bowel Dis 20, 2104-2114 (2014
43. Bchini, R., Vasiliou, V., Branlant, G., Talfournier, F., & Rahuel-Clermont, S. Retinoic acid biosynthesis catalyzed by retinal dehydrogenases relies on a rate-limiting conformational transition associated with substrate recognition. Chem Biol Interact 202, 78-84 (2013
44. Perez-Miller, S.J., & Hurley, T.D. Coenzyme isomerization is integral to catalysis in aldehyde dehydrogenase. Biochemistry 42, 7100-7109 (2003
45. Arend R.C., et al. Inhibition of Wnt/b-catenin pathway by niclosamide: A therapeutic target for ovarian cancer. Gynecol Oncol 134, 112-120 (2014
46. Soletti R.C., et al. Immunohistochemical analysis of retinoblastoma and b-catenin as an assistant tool in the differential diagnosis between Crohn's disease and ulcerative colitis. PLoS One 8, e70786 (2013
47. You, J., Nguyen, A.V., Albers, C.G., Lin, F., & Holcombe, R.F. Wnt pathwayrelated gene expression in inflammatory bowel disease. Dig Dis Sci 53, 1013-1019 (2008
48. Rafa H., et al. IL-23/IL-17A axis correlates with the nitric oxide pathway in inflammatory bowel disease: immunomodulatory effect of retinoic acid. J Interferon Cytokine Res 33, 355-368 (2013
49. Lu L., et al. Critical role of all-Trans retinoic acid in stabilizing human natural regulatory T cells under inflammatory conditions. Proc Natl Acad Sci USA 111, E3432-E3440 (2014
50. Bimczok D., et al. Human gastric epithelial cells contribute to gastric immune regulation by providing retinoic acid to dendritic cells. Mucosal Immunol 8, 533-544 (2014
51. Dunn, L.K., Gaar, L.R., Yentzer, B.A., O'Neill, J.L., & Feldman, S.R. Acitretin in dermatology: a review. J Drugs Dermatol 10, 772-782 (2011
52. Thielitz, A., & Gollnick, H. Topical retinoids in acne vulgaris: update on efficacy and safety. Am J Clin Dermatol 9, 369-381 (2008